Catecholamine exocytosis is diminished in R6/2 Huntington’s disease model mice
Open Access
- 13 August 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 103 (5) , 2102-2110
Abstract
In this work, the mechanisms responsible for dopamine (DA) release impairments observed previously in Huntington’s disease model R6/2 mice were evaluated. Voltammetrically measured DA release evoked in striatal brain slices from 12‐week old R6/2 mice by a single electrical stimulus pulse was only 19% of wild‐type (WT) control mice. Iontophoresis experiments suggest that the concentration of released DA is not diluted by a larger striatal extracellular volume arising from brain atrophy, but, rather, that striatal dopaminergic terminals have a decreased capacity for DA release. This decreased capacity was not due to an altered requirement for extracellular Ca2+, and, as in WT mice, the release in R6/2 mice required functioning vesicular transporters. Catecholamine secretion from individual vesicles was measured during exocytosis from adrenal chromaffin cells harvested from R6/2 and WT mice. While the number of exocytotic events was unchanged, the amounts released per vesicle were significantly diminished in R6/2 mice, indicating that vesicular catecholamines are present in decreased amounts. Treatment of chromaffin cells with 3‐nitropropionic acid decreased the vesicular release amount from WT cells by 50%, mimicking the release observed from untreated R6/2 cells. Thus, catecholamine release from tissues isolated from R6/2 mice is diminished because of impaired vesicle loading.Keywords
This publication has 43 references indexed in Scilit:
- Low stability of huntington muscle Mitochondria against Ca2+ in R6/2 miceAnnals of Neurology, 2006
- HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolismHuman Molecular Genetics, 2005
- Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfectTrends in Neurosciences, 2004
- Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin IIJournal of Biological Chemistry, 2003
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Etched carbon-fiber electrodes as amperometric detectors of catecholamine secretion from isolated biological cellsAnalytical Chemistry, 1991
- Regional Mitochondrial Respiratory Activity in Huntington's Disease BrainJournal of Neurochemistry, 1985
- Quantification of noradrenaline iontophoresisNature, 1980